Researchers have demonstrably advanced this development of the innovative treatment for ATTR-CM, utilizing the investigational drug. Early trial results indicates significant outcomes for patients diagnosed with this serious illness. This effort represents BridgeBio's commitment to addressing significant medical requirements in a heart disease f… Read More